ArticleMaterials today. Bio2026

Co-delivery of endoplasmic reticulum-targeted photosensitizer and Ido-1 inhibitor potentiates immunotherapeutic efficacy in triple-negative breast cancer.

Jia Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.